naltrexone and Parkinson Disease

naltrexone has been researched along with Parkinson Disease in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (18.18)	18.7374
1990's	2 (18.18)	18.2507
2000's	1 (9.09)	29.6817
2010's	5 (45.45)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Derkinderen, P; Grall-Bronnec, M; Laforgue, E; Verholleman, A; Verstuyft, C; Victorri-Vigneau, C	1
Duda, JE; Hurtig, H; Minger, J; Papay, K; Siderowf, A; Stern, M; Weintraub, D; Xie, SX	1
Galduróz, JC; Ramos, AC; Santos-Galduróz, RF	1
Groves, M; Liang, JW; Shanker, VL	1
Papay, K; Weintraub, D; Xie, SX	1
Berendse, HW; Nelis, EA; van den Heuvel, OA	1
Brotchie, JM; Hallett, PJ	1
Iacono, RP; Sandyk, R	1
Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM	1
Calne, DB; Chase, TN; Eisler, T; Nutt, JG; Rosin, AJ	1
Iversen, LL; Reisine, TD; Rossor, M; Spokes, E; Yamamura, HI	1

Reviews

2 review(s) available for naltrexone and Parkinson Disease

Article	Year
Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of International journal of molecular sciences, 2020, Apr-24, Volume: 21, Issue:8 Topics: Animals; Disease Susceptibility; Dopamine; Genetic Predisposition to Disease; Genotype; Humans; Naltrexone; Narcotic Antagonists; Parkinson Disease; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Sexual Dysfunction, Physiological; Sexuality; Treatment Outcome	2020
[Hypersexuality and other impulse control disorders in Parkinson's disease]. Nederlands tijdschrift voor geneeskunde, 2016, Volume: 160 Topics: Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease; Sexual Dysfunction, Physiological; Treatment Outcome	2016

Article

Year

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of

International journal of molecular sciences, 2020, Apr-24, Volume: 21, Issue:8

Topics: Animals; Disease Susceptibility; Dopamine; Genetic Predisposition to Disease; Genotype; Humans; Naltrexone; Narcotic Antagonists; Parkinson Disease; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Sexual Dysfunction, Physiological; Sexuality; Treatment Outcome

2020

[Hypersexuality and other impulse control disorders in Parkinson's disease].

Nederlands tijdschrift voor geneeskunde, 2016, Volume: 160

Topics: Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease; Sexual Dysfunction, Physiological; Treatment Outcome

2016

Trials

3 trial(s) available for naltrexone and Parkinson Disease

Article	Year
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology, 2014, Aug-26, Volume: 83, Issue:9 Topics: Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease	2014
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease	1994
Effect of an opiate antagonist on movement disorders. Archives of neurology, 1978, Volume: 35, Issue:12 Topics: Adult; Aged; Clinical Trials as Topic; Enkephalins; Humans; Huntington Disease; Middle Aged; Naloxone; Naltrexone; Parkinson Disease	1978

Other Studies

6 other study(ies) available for naltrexone and Parkinson Disease

Article	Year
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology, 2015, Mar-31, Volume: 84, Issue:13 Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease	2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology, 2015, Mar-31, Volume: 84, Issue:13 Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease	2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology, 2015, Mar-31, Volume: 84, Issue:13 Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease	2015
Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease; Prosencephalon; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reserpine; Tritium	2007
Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields. The International journal of neuroscience, 1994, Volume: 78, Issue:1-2 Topics: Adult; Electromagnetic Fields; Humans; Male; Melatonin; Naltrexone; Opioid Peptides; Parkinson Disease; Pineal Gland; Psychomotor Performance	1994
Alterations in brain opiate receptors in Parkinson's disease. Brain research, 1979, Sep-14, Volume: 173, Issue:2 Topics: Aged; Caudate Nucleus; Corpus Striatum; Dopamine; Humans; Middle Aged; Naloxone; Naltrexone; Parkinson Disease; Putamen; Receptors, Dopamine; Receptors, Opioid	1979